Alteco Medical is a Lund, Sweden-based ISO 13485-certified medical device company founded in 2002. The company's flagship product, the Alteco LPS Adsorber, serves to remove endotoxin (LPS) from the patient’s bloodstream. Endotoxin is the toxic part of gram-negative bacteria and is commonly found in sepsis patients, irrespective of the type of infection. As sepsis is a leading cause of death in modern intensive care, with nearly 49 million cases and 11 million deaths annually, the product's significance is compelling. The Alteco LPS Adsorber, available since 2007, plays a critical role in breaking the chain of immune system overreactions. This is achieved by removing endotoxin during extracorporeal treatment, ultimately stabilizing the patient’s hemodynamic parameters. The product, a class IIa medical device, employs a synthetic peptide to safely adsorb circulating endotoxin. This innovation is fundamental in effectively treating endotoxemia, which often requires additional therapy in sepsis cases. With its slogan, 'Alteco Medical – removing the threat', the company has positioned itself in the forefront of Health Care and Medical Devices industries, addressing a critical need in modern healthcare.
There is no investment information
No recent news or press coverage available for Alteco Medical.